Infections with biological therapy: strategies for risk minimization in tropical and developing countries

Authors

  • Carlos E. Pérez-Díaz Servicios y Asesorías en Infectología (SAI), Bogotá, Colombia
  • Erika Uribe-Pardo Servicios y Asesorías en Infectología (SAI), Bogotá, Colombia
  • Omar-Javier Calixto Servicios y Asesorías en Infectología (SAI), Bogotá, Colombia
  • Álvaro A. Faccini-Martínez Centro de Ciências da Saúde, Universidade Federal do Espírito Santo, Vitória, ES, Brazil
  • Alfonso J. Rodriguez-Morales Faculty of Health Sciences, Universidad Tecnológica de Pereira, Pereira, Risaralda, Colombia

DOI:

https://doi.org/10.3855/jidc.8222

Keywords:

autoimmune disease, rheumatoid arthritis, tuberculosis, biological therapy, infectious diseases

Abstract

In recent decades, biological therapy has enabled disease activity control and improved quality of life in patients with autoimmune diseases. These therapies that are involved in immune response modifications and change multiple immunological pathways induce an incremental risk for certain infectious diseases. Though there have been recent advances in risk assessment for biological therapy, there is a lack of data and recommendations for assessing risks in populations with high prevalence of infectious diseases, such as those located in tropical areas and developing countries. We performed a review on infections with biological therapy as well strategies for risk minimization in areas with a high prevalence of tropical diseases.

Author Biographies

Carlos E. Pérez-Díaz, Servicios y Asesorías en Infectología (SAI), Bogotá, Colombia

Infectious Disease Department, Clínica Marly, Bogotá, Colombia.
Infectious Disease Department, Hospital de la Samaritana, Bogotá,

Álvaro A. Faccini-Martínez, Centro de Ciências da Saúde, Universidade Federal do Espírito Santo, Vitória, ES, Brazil

Programa de Pós-Graduação em Doenças Infecciosas, Centro de Ciências da Saúde, Universidade Federal do Espírito Santo, Vitória, ES, Brazil

Alfonso J. Rodriguez-Morales, Faculty of Health Sciences, Universidad Tecnológica de Pereira, Pereira, Risaralda, Colombia

MD, MSc, DTM&H, FRSTM&H(Lon), FFTM RCPS(Glasg), PhD Candidate.

Advisor on Public Health, Epidemiology, Methodology and Biostatistics.

Researcher in Public Health and Tropical, Parasitic and Infectious Diseases.

Faculty of Health Sciences, Universidad Tecnológica de Pereira, Pereira, Risaralda, Colombia.

Associated Researcher Ad Honorem, Instituto de Investigaciones José Witremundo Torrealba (former Trujillan Center for Parasitological Research), Universidad de Los Andes, Trujillo, Venezuela.

Downloads

Published

2016-12-30

How to Cite

1.
Pérez-Díaz CE, Uribe-Pardo E, Calixto O-J, Faccini-Martínez Álvaro A, Rodriguez-Morales AJ (2016) Infections with biological therapy: strategies for risk minimization in tropical and developing countries. J Infect Dev Ctries 10:1278–1285. doi: 10.3855/jidc.8222

Issue

Vol. 10 No. 12: December 2016

Section

Reviews

License

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
Crossref
Scopus
Google Scholar
Europe PMC